Clinical Trial Update: Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ [Phase 3]

View source ↗

Summary

A Phase 3 trial update on delayed sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: Uppsala University | Conditions: DCIS, Breast Cancer | Phase 3 | Status: RECRUITING